Ba Hongjun, Peng Huimin, He Xiufang, Cheng Liangping, Lin Yuese, Li Xuandi, Wang Huishen, Qin Youzhen
Department of Pediatric Cardiology, Heart Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Key Laboratory on Assisted Circulation, Ministry of Health, Guangzhou, China.
Front Pediatr. 2021 Jun 11;9:668316. doi: 10.3389/fped.2021.668316. eCollection 2021.
Sitosterolemia is a rare condition in children and is often misdiagnosed as familial hypercholesterolemia. Serious complications can result if not treated promptly and effectively. When pediatric patients are diagnosed with sitosterolemia, vascular, and cardiac studies are important to evaluate for the presence of atherosclerosis. Few cases of severe atherosclerotic heart disease in children with sitosterolemia have been reported, making this case worthy of presentation. Here, we report a case of sitosterolemia in an 8-year-old child. The patient presented with severe hypercholesterolemia and xanthoma. He was diagnosed two and a half years prior with familial hypercholesterolemia because his father had elevated cholesterol levels. After conventional treatment, the patient was dissatisfied with lipid level control and visited our hospital for further management. Genetic tests of the patient and parents found mutations in intron 7 (NM 022436.2, c.904+1G>A) and intron 9 (NM 022436.2, C. 1324+1de1G) of ABCG5. The 7 intron mutation was from his mother, and the 9 intron mutation was from his father. The patient was diagnosed with sitosterolemia. The child was treated with ezetimibe, a low plant sterol diet, and clopidogrel anticoagulant therapy. After 3 months of treatment, the blood lipid level was significantly lower. Genetic testing should be completed as soon as possible to avoid misdiagnosis in children with abnormally elevated hypercholesterolemia who have a family history of elevated cholesterol. In addition, clinicians should rule out great arterial lesions and be vigilant in evaluating patients for systemic arterial disease and atherosclerosis.
谷甾醇血症在儿童中是一种罕见病症,常被误诊为家族性高胆固醇血症。若不及时有效治疗,可能会导致严重并发症。当儿科患者被诊断为谷甾醇血症时,进行血管和心脏检查对于评估动脉粥样硬化的存在很重要。很少有关于谷甾醇血症患儿发生严重动脉粥样硬化性心脏病的病例报道,因此该病例值得介绍。在此,我们报告一例8岁儿童谷甾醇血症病例。该患者表现为严重高胆固醇血症和黄色瘤。两年半前,因其父亲胆固醇水平升高,他被诊断为家族性高胆固醇血症。经过常规治疗后,患者对血脂水平控制不满意,前来我院进一步治疗。对患者及其父母进行基因检测发现,ABCG5基因的第7内含子(NM 022436.2,c.904+1G>A)和第9内含子(NM 022436.2,C. 1324+1de1G)发生突变。第7内含子突变来自其母亲,第9内含子突变来自其父亲。该患者被诊断为谷甾醇血症。该患儿接受了依折麦布治疗、低植物甾醇饮食和氯吡格雷抗凝治疗。治疗3个月后,血脂水平显著降低。对于有胆固醇升高家族史且高胆固醇血症异常升高的儿童,应尽快完成基因检测以避免误诊。此外,临床医生应排除大动脉病变,并在评估患者是否存在系统性动脉疾病和动脉粥样硬化时保持警惕。